The Centre for Disease Control (CDC) estimates that 2 to 3 in every 50 babies (4–6%) who develop Group B Streptococcus (GBS) disease will die and on average, about 1 in 20 non-pregnant adults with serious GBS infections dies. Working with some of the top researchers in Australia, NEXSEN BioTech is ...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2021 (5 years)
Address:
MELBOURNE, VIC 3000, AU
Employees by Department
- Operations (1)
- The Rest (4)
- Total (5)
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has NEXSEN been operating for?
- What is the funding status of NEXSEN?
- Where is NEXSEN's headquarter?
- What NEXSEN's spending power?
- Does NEXSEN have a presence in the domain it operates in?

